CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


AV-COVID-19Wiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D058186 Acute Kidney Injury NIH 0.33
D014947 Wounds and Injuries NIH 0.29

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Adaptive Phase IB-II Trial Of Vaccine Consisting Of Autologous Dendritic Cells Loaded With Antigens From Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), With Or Without GM-CSF, In Frontline Healthcare Providers And Responders

This is an adaptive Phase IB-II trial of a vaccine consisting of autologous dendritic cells loaded with antigens from SARS-CoV-2, with or without GM-CSF, to prevent COVID-19 in frontline healthcare providers and first responders.

NCT04386252 COVID-19 Biological: AV-COVID-19

Primary Outcomes

Description: Confirm safety of AV-COVID-19 by adverse event monitoring

Measure: Confirm safety

Time: 6 months

Secondary Outcomes

Description: Measurement of IgG and IgM in subject blood

Measure: Suggestion of efficacy

Time: 6 months

Description: Measurement of IgG and IgM in subject blood

Measure: Optimal dose of SARS-CoV-2 antigen

Time: 6 months

Description: Measurement of IgG and IgM in subject blood

Measure: Advantage of administering vaccine admixed with GM-CSF

Time: 6 months

Description: Measurement of IgG and IgM in subject blood

Measure: Frequency of detecting IgG against SARS-CoV-2 in blood after vaccination

Time: 6 months


No related HPO nodes (Using clinical trials)